These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22914463)

  • 1. Association of polymorphisms in neuroprotection and oxidative stress genes and neurodevelopmental outcomes after preterm birth.
    Costantine MM; Clark EA; Lai Y; Rouse DJ; Spong CY; Mercer BM; Sorokin Y; Thorp JM; Ramin SM; Malone FD; Carpenter M; Miodovnik M; O'Sullivan MJ; Peaceman AM; Caritis SN
    Obstet Gynecol; 2012 Sep; 120(3):542-50. PubMed ID: 22914463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Variation, Magnesium Sulfate Exposure, and Adverse Neurodevelopmental Outcomes Following Preterm Birth.
    Clark EAS; Weiner SJ; Rouse DJ; Mercer BM; Reddy UM; Iams JD; Wapner RJ; Sorokin Y; Malone FD; O'Sullivan MJ; Peaceman AM; Hankins GDV; Dudley DJ; Caritis SN;
    Am J Perinatol; 2018 Aug; 35(10):1012-1022. PubMed ID: 29510423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-Specific Genetic Susceptibility to Adverse Neurodevelopmental Outcome in Offspring of Pregnancies at Risk of Early Preterm Delivery.
    Varner MW; Costantine MM; Jablonski KA; Rouse DJ; Mercer BM; Leveno KJ; Reddy UM; Buhimschi C; Wapner RJ; Sorokin Y; Thorp JM; Ramin SM; Malone FD; Carpenter M; O'sullivan MJ; Peaceman AM; Dudley DJ; Caritis SN;
    Am J Perinatol; 2020 Feb; 37(3):281-290. PubMed ID: 30731481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Predisposition to Adverse Neurodevelopmental Outcome of Extremely Low Birth Weight Infants.
    Varner MW; Thom EA; Cotten CM; Hintz SR; Page GP; Rouse DJ; Mercer BM; Costantine MM; Sorokin Y; Thorp JM; Ramin SM; Carpenter MW; O'Sullivan MJ; Peaceman AM; Saade GR; Dudley DJ; Caritis SN;
    Am J Perinatol; 2024 May; 41(S 01):e2710-e2716. PubMed ID: 37726016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms and spontaneous preterm birth.
    Gibson CS; MacLennan AH; Dekker GA; Goldwater PN; Dambrosia JM; Munroe DJ; Tsang S; Stewart C; Nelson KB
    Obstet Gynecol; 2007 Feb; 109(2 Pt 1):384-91. PubMed ID: 17267840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnesium sulfate, chorioamnionitis, and neurodevelopment after preterm birth.
    Kamyar M; Manuck TA; Stoddard GJ; Varner MW; Clark E
    BJOG; 2016 Jun; 123(7):1161-6. PubMed ID: 26036660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Childhood neurodevelopment after spontaneous versus indicated preterm birth.
    Nuss EE; Spiegelman J; Turitz AL; Gyamfi-Bannerman C
    Am J Obstet Gynecol MFM; 2020 May; 2(2):100082. PubMed ID: 33345968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal Tobacco Exposure and Childhood Neurodevelopment among Infants Born Prematurely.
    Robbins LS; Blanchard CT; Sinkey RG; Harris SL; Tita AT; Harper LM
    Am J Perinatol; 2021 Feb; 38(3):218-223. PubMed ID: 32862421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic chorioamnionitis and risk of neurodevelopmental impairment at age 10 years among extremely preterm infants born before 28 weeks of gestation.
    Venkatesh KK; Leviton A; Hecht JL; Joseph RM; Douglass LM; Frazier JA; Daniels JL; Fry RC; O'Shea TM; Kuban KCK
    Am J Obstet Gynecol; 2020 Nov; 223(5):745.e1-745.e10. PubMed ID: 32387324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodevelopmental outcome in extremely preterm infants at 2.5 years after active perinatal care in Sweden.
    Serenius F; Källén K; Blennow M; Ewald U; Fellman V; Holmström G; Lindberg E; Lundqvist P; Maršál K; Norman M; Olhager E; Stigson L; Stjernqvist K; Vollmer B; Strömberg B;
    JAMA; 2013 May; 309(17):1810-20. PubMed ID: 23632725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of cord serum cytokines with neurodevelopmental outcomes.
    Varner MW; Marshall NE; Rouse DJ; Jablonski KA; Leveno KJ; Reddy UM; Mercer BM; Iams JD; Wapner RJ; Sorokin Y; Thorp JM; Malone FD; Carpenter M; O'Sullivan MJ; Peaceman AM; Hankins GD; Dudley DJ; Caritis SN;
    Am J Perinatol; 2015 Feb; 30(2):115-22. PubMed ID: 24936937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal obesity and neuroprotective magnesium sulfate.
    McPherson J; Smiley S; Stamilio D
    Am J Obstet Gynecol; 2015 Oct; 213(4):582.e1-6. PubMed ID: 26116874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnesium sulphate at 30 to 34 weeks' gestational age: neuroprotection trial (MAGENTA)--study protocol.
    Crowther CA; Middleton PF; Wilkinson D; Ashwood P; Haslam R;
    BMC Pregnancy Childbirth; 2013 Apr; 13():91. PubMed ID: 23570677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodevelopmental outcomes of preterm infants conceived by assisted reproductive technology.
    Roychoudhury S; Lodha A; Synnes A; Abou Mehrem A; Canning R; Banihani R; Beltempo M; Theriault K; Yang J; Shah PS; Soraisham AS; ; ;
    Am J Obstet Gynecol; 2021 Sep; 225(3):276.e1-276.e9. PubMed ID: 33798481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodevelopmental status of preterm newborns at infancy, born at a tertiary care center in Turkey.
    Saldir M; Sarici SU; Bakar EE; Ozcan O
    Am J Perinatol; 2010 Feb; 27(2):121-8. PubMed ID: 19504426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between initial neonatal and early childhood outcomes following preterm birth.
    Manuck TA; Sheng X; Yoder BA; Varner MW
    Am J Obstet Gynecol; 2014 May; 210(5):426.e1-9. PubMed ID: 24793722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial.
    Crowther CA; Hiller JE; Doyle LW; Haslam RR;
    JAMA; 2003 Nov; 290(20):2669-76. PubMed ID: 14645308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in neurodevelopmental outcomes at 18 to 22 months' corrected age among infants of less than 25 weeks' gestational age born in 1993-1999.
    Hintz SR; Kendrick DE; Vohr BR; Poole WK; Higgins RD;
    Pediatrics; 2005 Jun; 115(6):1645-51. PubMed ID: 15930228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrapartum opioid analgesia and childhood neurodevelopmental outcomes among infants born preterm.
    Robbins LS; Perez WM; Casey BM; Blanchard CT; Tita AT; Harper LM
    Am J Obstet Gynecol MFM; 2021 Jul; 3(4):100372. PubMed ID: 33831589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and clinical contributions to cerebral palsy: a multi-variable analysis.
    O'Callaghan ME; Maclennan AH; Gibson CS; McMichael GL; Haan EA; Broadbent JL; Baghurst PA; Goldwater PN; Dekker GA;
    J Paediatr Child Health; 2013 Jul; 49(7):575-81. PubMed ID: 23773706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.